I agree that in these times, Cytosorbents should promote a "significantly reduced price for all of humanity" to get the world through this. Remember that we have 80% gross margins. Once people use, and if they deem effective (which has evidential support), word of mouth, and anecdotal evidence will drive Cytosorb volume. Secondarily, the company doesn't look bad from a p.r. perspective, either. Most importantly, lives will be saved as we have seen from study, after study, after study.
I agree that in these times, Cytosorbents should promote a "significantly reduced price for all of humanity" to get the world through this. Remember that we have 80% gross margins. Once people use, and if they deem effective (which has evidential support), word of mouth, and anecdotal evidence will drive Cytosorb volume. Secondarily, the company doesn't look bad from a p.r. perspective, either. Most importantly, lives will be saved as we have seen from study, after study, after study.